This opportunity funds translational and clinical research aimed at advancing precision medicine and therapeutics for pregnant women, lactating women, infants, children, and adolescents. It supports development of novel tools, discovery of new therapeutics, improved patient-provider communication, and scaling evidence-based interventions to enhance medication safety and effectiveness across these populations.
Eligible applicants include a wide range of government entities, educational institutions, tribal organizations, nonprofits, for-profit organizations, small businesses, faith-based and community organizations, and foreign institutions. Specific eligibility details are extensive and include federal a
